Please Wait.....
Report
Psychedelic Drugs Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
Market Report I 2023-01-23 I 110 Pages I Mordor Intelligence
The psychedelic drugs market is expected to register a CAGR of 7% during the forecast period.
During the COVID-19 pandemic, there was a rising demand for psychedelic drugs, which is driving the market growth. The COVID-19 infection rate was rising exponentially across the world. Due to the sudden imposition of the lockdown by the governments worldwide, people everywhere suffered from severe trauma and stress. For instance, according to the Frontiers Journal published in 2020 by the department of psychology in Latin America, the COVID-19 pandemic led to a rise in anxiety, stress, and depression. Therefore, psychedelic drugs play a potential role in treating frequently occurring mental disorders, thus driving the market growth.
The crucial factors driving the market's growth were a rise in awareness toward mental health and a rapid expansion in research and development in exploring novel treatments. A rapid increase in the cases of depression, stress, and other mental disorders resulted in the increasing awareness of mental health among the population worldwide. These mental disorders could result in severe conditions if untreated. The need for handling excess stress, anxiety, and other mental disorders plays a vital role in the market's growth. Lack of healthcare structure and facilities can make these diseases fatal, which is the case in many developing and under-developed countries.
Mental health issues are increasing among people globally. As per a report by the World Health Organization (WHO) published in 2021, mental health disorders affect 13% of the world's population. The report also stated that mental health conditions now cause 1 in 5 years lived in disability. Such severe conditions have led people toward the treatment. Moreover, several organizations have launched awareness campaigns that increased the usage of psychedelic drugs to treat mental disorders. For instance, in 2021, The Federation Internationale de Football Association (FIFA) launched Reach Out, a campaign to raise awareness about the symptoms of mental conditions and take actions for better mental health.
The growing prevalence of mental depression, anxiety, stress, and availability of off-label drugs propelled the demand for the psychedelic drugs market. As per the National institute of mental health, in 2020, in the United States, young adults aged 18-25 years and adults of about 30 were having severe mental disorders, which required treatment. As per the statistics published by the Lancet Public health in 2021, 6.4% of the population suffered from depression and other mental conditions. Therefore, these high and increasing prevalence rates of mental health disorders resulted in the growth of the psychedelic drugs market.
Psychedelic Drugs Market Trends
Hospitals Pharmacies Segment Expected to Hold a Major Market Share
During the COVID-19 pandemic, the demand for psychedelic drugs increased as the hospital pharmacies were widely occupied with treating the patient's mental health disorders, further boosting segment growth.
The increasing awareness among people worldwide regarding their mental health and usage of psychedelic drugs for specific indications are driving the growth of hospital pharmacies as a distribution channel. The psychedelic drugs have also shown anti-inflammatory activity, further driving the market's growth.
The increasing prevalence of depression and other mental disorders among the population across the globe resulted in the need for handling mental health for a better quality of lifestyle. The treatment for such mental illness conditions using psychedelic drugs is expected to drive the market's growth. Consumers tend to visit the hospital pharmacies for safe and authorized drugs, which results in the hospital pharmacies' distribution channel growth.
North America Expected to Hold a Significant Share and Expected to do the Same in the Forecast Period
The United States is the most affected country globally, as most of the population suffers from mental health disorders. Thus, the demand is significantly higher in the North American region as the patient population is increasing compared to other countries.
North America is expected to hold a major market share in the global psychedelic drugs market due to the rise in mental illness and the increasing prevalence and incidence of mental disorder problems. In 2020, North America held a major market share for psychedelic drugs, and this trend is likely to remain the same in the forecast period. The incidence of severe mental health disorders, like depression, stress, obsessive-compulsive disorders, is also high in the United States. As per the National Institute of Mental Health (NIMH) statistics, in 2020, an estimated 52.9 million adults aged 18 or older in the United States had a mental illness. The report also stated that mental illness was higher among females than males at 25.8%. As per the mental health first aid report in 2020, the most common mental illness in the United States was anxiety disorder, which affected 40 million adults, 18.1% of the population. The high prevalence of these mental disorders leads to severe health issues, the leading causes of death and disability in America. Rising awareness of mental health disorders such as depression, obsessive compulsion, and stress is expected to boost the psychedelic drug market growth. An increase in economic stress, unstable family structures, and other causes are further estimated to accelerate the market's growth.
Moreover, an increase in R&D and favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent. ?
Psychedelic Drugs Market Competitor Analysis
The psychedelic drugs market is fragmented, competitive, and consists of several major players. A few major players are currently dominating the market in terms of market share. Some companies currently dominating the market include Jazz Pharmaceuticals, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, and Pfizer Inc., which hold substantial market shares.
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Awareness toward Mental Health
4.2.2 Rapid Expansion in R&D in Exploring Novel Treatments
4.3 Market Restraints
4.3.1 Increasing Side Effects of Psychedelic Drugs
4.3.2 Stringent Regulatory Framework
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Drug Type
5.1.1 Gamma Hydroxybutyric Acid (GHB)
5.1.2 Ketamine
5.1.3 Other Drug Types
5.2 By Application
5.2.1 Treatment Resistant Depression
5.2.2 Opiate Addiction
5.2.3 Post-traumatic Stress Disorder
5.2.4 Narcolepsy
5.2.5 Panic Disorders
5.3 By Distribution Channel
5.3.1 Hospital pharmacy
5.3.2 Retail pharmacy
5.3.3 Other Distribution Channels
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 COMPANY PROFILES
6.1.1 Jazz Pharmaceuticals
6.1.2 Hikma Pharmaceuticals
6.1.3 Celon Pharmaceuticals
6.1.4 Cybin Corp.
6.1.5 Pfizer Inc.
6.1.6 Numinus
6.1.7 Mind care Health Inc.
6.1.8 Mind Medicine
6.1.9 Avadel
6.1.10 PharmaTher Holdings Ltd
6.1.11 NRx Pharmaceuticals Inc.
6.1.12 Seelos Therapeutics
6.1.13 Havn Life
6.1.14 Revive Therapeutics
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security